Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 12 holding rows worth $369,450,641.

Accession
0001012975-26-000154
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 12 entries on the cover page, a total value of $369,450,641 stated on the cover page (in dollars after the unit check, H1), rows summing to $369,450,641 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Vanguard FTSE All-World ex-US ETF922042775SHS2,990,084$219,950,579dollars as filed
Vanguard Value ETF922908744SHS520,000$99,314,800dollars as filed
ISHARES TR46429B598MSCI INDIA ETF369,600$19,976,880dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,573,761$8,498,309dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM989,410$8,093,374dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,627,643$3,284,554dollars as filed
SPY78462F103SHS4,104$2,798,600dollars as filed
RAPT THERAPEUTICS INC75382E208COM NEW82,234$2,785,266dollars as filed
ALECTOR INC014442107COMMON STOCK1,307,858$2,040,258dollars as filed
SURROZEN INC86889P208COMMON STOCK87,696$1,981,930dollars as filed
TENAYA THERAPEUTICS INC87990A106COM1,015,705$722,674dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203170,833$3,417dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-26-000154this filing2026-02-17acceptance time not in the bulk data set